Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar )

Background: This study was conducted to investigate whether mRNA vaccine technology could be adapted for the ectothermic vertebrate Atlantic salmon ( Salmo salar ). Lipid nanoparticle (LNP) technology has been developed and optimized for mRNA vaccines in mammals, stabilizing mRNA and facilitating it...

Full description

Bibliographic Details
Published in:Vaccines
Main Authors: Lars Ole Sti Dahl, Sjoerd Hak, Stine Braaen, Alicja Molska, Francesca Rodà, Jeremie Parot, Øystein Wessel, Johanna Hol Fosse, Håvard Bjørgen, Sven Even Borgos, Espen Rimstad
Format: Article in Journal/Newspaper
Language:English
Published: MDPI AG 2024
Subjects:
R
Online Access:https://doi.org/10.3390/vaccines12070788
https://doaj.org/article/ee3adfb08fe94cae93f79fc993143548
id ftdoajarticles:oai:doaj.org/article:ee3adfb08fe94cae93f79fc993143548
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:ee3adfb08fe94cae93f79fc993143548 2024-09-15T17:55:59+00:00 Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar ) Lars Ole Sti Dahl Sjoerd Hak Stine Braaen Alicja Molska Francesca Rodà Jeremie Parot Øystein Wessel Johanna Hol Fosse Håvard Bjørgen Sven Even Borgos Espen Rimstad 2024-07-01T00:00:00Z https://doi.org/10.3390/vaccines12070788 https://doaj.org/article/ee3adfb08fe94cae93f79fc993143548 EN eng MDPI AG https://www.mdpi.com/2076-393X/12/7/788 https://doaj.org/toc/2076-393X doi:10.3390/vaccines12070788 2076-393X https://doaj.org/article/ee3adfb08fe94cae93f79fc993143548 Vaccines, Vol 12, Iss 7, p 788 (2024) mRNA vaccination lipid nanoparticle technology Atlantic salmon Medicine R article 2024 ftdoajarticles https://doi.org/10.3390/vaccines12070788 2024-08-05T17:48:50Z Background: This study was conducted to investigate whether mRNA vaccine technology could be adapted for the ectothermic vertebrate Atlantic salmon ( Salmo salar ). Lipid nanoparticle (LNP) technology has been developed and optimized for mRNA vaccines in mammals, stabilizing mRNA and facilitating its delivery into cells. However, its utility at the temperatures and specific biological environments present in ectotherms remains unclear. In addition, it is unknown if modified mRNA containing non-canonical nucleotides can correctly translate in salmonid cells. Methods: We used an mRNA transcript coding for enhanced green fluorescence protein, flanked by the untranslated regions of the hemagglutinin-esterase gene of the infectious salmon anemia virus, and a 120-base-long poly(A) tail. The mRNA was generated via in vitro transcription where uridine residues were replaced with N1-methyl-pseudouridines, and then encapsulated in LNPs. Results: When transfected into the salmonid cell line CHH-1, the mRNA-LNP construct induced expression of EGFP. Furthermore, when mRNA-LNPs were injected intramuscularly into salmon, in vivo protein expression was demonstrated via immunohistochemistry. EGFP was observed in cells infiltrating the spaces between muscle cells in a focal inflammatory response. Conclusion: The results indicate that N1-methyl-pseudouridine-modified mRNA encapsulated in LNPs can be used to express antigens of interest in salmonid fish. Article in Journal/Newspaper Atlantic salmon Salmo salar Directory of Open Access Journals: DOAJ Articles Vaccines 12 7 788
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic mRNA vaccination
lipid nanoparticle technology
Atlantic salmon
Medicine
R
spellingShingle mRNA vaccination
lipid nanoparticle technology
Atlantic salmon
Medicine
R
Lars Ole Sti Dahl
Sjoerd Hak
Stine Braaen
Alicja Molska
Francesca Rodà
Jeremie Parot
Øystein Wessel
Johanna Hol Fosse
Håvard Bjørgen
Sven Even Borgos
Espen Rimstad
Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar )
topic_facet mRNA vaccination
lipid nanoparticle technology
Atlantic salmon
Medicine
R
description Background: This study was conducted to investigate whether mRNA vaccine technology could be adapted for the ectothermic vertebrate Atlantic salmon ( Salmo salar ). Lipid nanoparticle (LNP) technology has been developed and optimized for mRNA vaccines in mammals, stabilizing mRNA and facilitating its delivery into cells. However, its utility at the temperatures and specific biological environments present in ectotherms remains unclear. In addition, it is unknown if modified mRNA containing non-canonical nucleotides can correctly translate in salmonid cells. Methods: We used an mRNA transcript coding for enhanced green fluorescence protein, flanked by the untranslated regions of the hemagglutinin-esterase gene of the infectious salmon anemia virus, and a 120-base-long poly(A) tail. The mRNA was generated via in vitro transcription where uridine residues were replaced with N1-methyl-pseudouridines, and then encapsulated in LNPs. Results: When transfected into the salmonid cell line CHH-1, the mRNA-LNP construct induced expression of EGFP. Furthermore, when mRNA-LNPs were injected intramuscularly into salmon, in vivo protein expression was demonstrated via immunohistochemistry. EGFP was observed in cells infiltrating the spaces between muscle cells in a focal inflammatory response. Conclusion: The results indicate that N1-methyl-pseudouridine-modified mRNA encapsulated in LNPs can be used to express antigens of interest in salmonid fish.
format Article in Journal/Newspaper
author Lars Ole Sti Dahl
Sjoerd Hak
Stine Braaen
Alicja Molska
Francesca Rodà
Jeremie Parot
Øystein Wessel
Johanna Hol Fosse
Håvard Bjørgen
Sven Even Borgos
Espen Rimstad
author_facet Lars Ole Sti Dahl
Sjoerd Hak
Stine Braaen
Alicja Molska
Francesca Rodà
Jeremie Parot
Øystein Wessel
Johanna Hol Fosse
Håvard Bjørgen
Sven Even Borgos
Espen Rimstad
author_sort Lars Ole Sti Dahl
title Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar )
title_short Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar )
title_full Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar )
title_fullStr Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar )
title_full_unstemmed Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon ( Salmo salar )
title_sort implementation of mrna–lipid nanoparticle technology in atlantic salmon ( salmo salar )
publisher MDPI AG
publishDate 2024
url https://doi.org/10.3390/vaccines12070788
https://doaj.org/article/ee3adfb08fe94cae93f79fc993143548
genre Atlantic salmon
Salmo salar
genre_facet Atlantic salmon
Salmo salar
op_source Vaccines, Vol 12, Iss 7, p 788 (2024)
op_relation https://www.mdpi.com/2076-393X/12/7/788
https://doaj.org/toc/2076-393X
doi:10.3390/vaccines12070788
2076-393X
https://doaj.org/article/ee3adfb08fe94cae93f79fc993143548
op_doi https://doi.org/10.3390/vaccines12070788
container_title Vaccines
container_volume 12
container_issue 7
container_start_page 788
_version_ 1810432205600587776